Vaccine Uptake in the US After Full Food and Drug Administration Approval of the BNT162b2 mRNA COVID-19 Vaccine.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 35385093.
- Also identified by DOI 10.1001/jamanetworkopen.2022.6108 and PMC identifier 8987898.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cross-sectional study examines the association of full approval of the BNT162b2 mRNA vaccine by the US Food and Drug Administration (FDA) with subsequent US uptake of COVID-19 vaccines of any kind.
Medical subject headings
- COVID-19
- Vaccines